Details for New Drug Application (NDA): 016909
✉ Email this page to a colleague
The generic ingredient in LIDEX is fluocinonide. There are nine drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.
Summary for 016909
Tradename: | LIDEX |
Applicant: | Alvogen |
Ingredient: | fluocinonide |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016909
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 016909
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alvogen | LIDEX | fluocinonide | OINTMENT;TOPICAL | 016909-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription